Pharmacoepidemiological research using French reimbursement databases: yes we can!
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Purpose: To describe the reimbursement databases available in France for pharmacoepidemiological research and their use. Methods: France has a publicly funded health system that systematically covers the population. Within this system, three main insurance schemes provide health services to citizens in France and each have their own reimbursement database. Together these three databases cover almost 97% of the French population (respectively for 54.5, 3.6, and 3.3 million individuals, and a total of 61.4 million individuals). Data in these concern patients, prescribers, all the medical acts reimbursed, prescription and undertaking of laboratory tests (but without results), private hospital data, partial public hospital data and vital status. Their use is regulated but access is free and the data are anonymous. PubMed and Scopus were searched for relevant studies published from January 1988 to June 2009. Results: 110 published studies were included. The topics and the study characteristics were extremely wide‐ranging. The studies assessed patterns of drug use, have tested interventions, supported or improved prescribing practices, tested compliance with the French governmental Health guidelines, assessed physicians' prescribing practices and performed economic and cost‐effectiveness assessments. The number of articles published increased greatly between 2002 and 2003. Conclusions: The French reimbursement databases were greatly used over the last 20 years. They can provide data on exposure to drugs and can be used to study patterns of drug utilization although their limitations must be considered. Copyright © 2010 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychotropic drugs use and risk of heat-related hospitalisation
Martin-Latry, K., Goumy, M.-P., Latry, P., Gabinski, C., Bégaud, B., Faure, I., & Verdoux, H. (2007) · European Psychiatry · doi:10.1016/j.eurpsy.2007.03.007 · Cited by 190
Self-citationDifferences between clinical trials and postmarketing use
Martin, K., Bégaud, B., Latry, P., Miremont‐Salamé, G., Fourrier, A., & Moore, N. (2004) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01953.x · Cited by 157
Self-citation
Cited by
Bezin, J., Duong, M., Lassalle, R., Droz, C., Pariente, A., Blin, P., & Moore, N. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4233 · Cited by 584
French national health insurance information system and the permanent beneficiaries sample
Tuppin, P., de Roquefeuil, L., Weill, A., Ricordeau, P., & Merlière, Y. (2010) · Revue d'Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2010.04.005 · Cited by 399
Neumann, A., Weill, A., Ricordeau, P., Fagot, J. P., Alla, F., & Allemand, H. (2012) · Diabetologia · doi:10.1007/s00125-012-2538-9 · Cited by 284
Huiart, L., Bouhnik, A.-D., Rey, D., Tarpin, C., Cluze, C., Bendiane, M. K., Viens, P., & Giorgi, R. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.03.004 · Cited by 97
Blin, P., Dureau‐Pournin, C., Foubert‐Samier, A., Grolleau, A., Corbillon, E., Jové, J., Lassalle, R., Robinson, P., Poutignat, N., Droz‐Perroteau, C., et al. (2015) · European Journal of Neurology · doi:10.1111/ene.12592 · Cited by 74
Metadata
- Authors
- Martin‐Latry, K., & Bégaud, B.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2010-02-24
- Volume
- 19
- Issue
- 3
- Pages
- 256-265
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2133228717
- Cited by
- 147
- References
- 2
- FWCI
- 27.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacoepidemiological research using French reimbursement databases: yes we can! https://app.cochat.ai/papers/10.1002/pds.1912
- The paper
- Martin‐Latry, K., & Bégaud, B. (2010). Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.1912
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.